EDA ligand triggers plasma membrane trafficking of its receptor EDAR via PKA activation and SNAP23-containing complexes
- Cell Biosci. 2023 Jul 10;13(1):128. doi: 10.1186/s13578-023-01082-8.
- 1. School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
- 2. Department of Psychology, Eastern Illinois University, Charleston, IL, 61920, USA.
- 3. Laboratory of Genetics and Genomics, NIA/NIH-IRP, 251 Bayview Blvd, Room 10B014, Baltimore, MD, 21224, USA.
- 4. School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, China. [email protected].
Background: Ectodysplasin-A (EDA), a skin-specific TNF ligand, interacts with its membrane receptor EDAR to trigger EDA signaling in skin appendage formation. Gene mutations in EDA signaling cause Anhidrotic/Hypohidrotic Ectodermal Dysplasia (A/HED), which affects the formation of skin appendages including hair, teeth, and several exocrine glands.
Results: We report that EDA triggers the translocation of its receptor EDAR from a cytosolic compartment into the plasma membrane. We use protein affinity purification to show that upon EDA stimulation EDAR associates with SNAP23-STX6-VAMP1/2/3 vesicle trafficking complexes. We find that EDA-dependent PKA activation is critical for the association. Notably, either of two HED-linked EDAR mutations, T346M and R420W, prevents EDA-induced EDAR translocation; and both EDA-induced PKA activation and SNAP23 are required for Meibomian gland (MG) growth in a skin appendage model.
Conclusions: Overall, in a novel regulatory mechanism, EDA increases plasma membrane translocation of its own receptor EDAR, augmenting EDA-EDAR signaling in skin appendage formation. Our findings also provide PKA and SNAP23 as potential targets for the intervention of HED.
-
Cat. No.Product NameCategory/Application